JAK1 and JAK2 are involved in the immunopathogenesis of RA by increasing the turnover of active, phosphorylated STAT1 and STAT3, and preventing chemotaxis toward IL-8. The gene discussed is CXCL8; the disease is rheumatoid arthritis.